Holen Sie sich die Stockscreener-App
3.06
9.68%
0.27
Finanzdaten der Insight Molecular Diagnostics Inc-Aktie (IMDX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
646.87%
0.239
|
0.032 | 1.139 | 0.26 | 0.518 |
| Cost Of Revenue |
382.35%
0.082
|
0.017 | 0.643 | 0.121 | 0.168 |
| Gross Profit |
946.67%
0.157
|
0.015 | 0.496 | 0.139 | 0.35 |
| Operating Expenses |
161.04%
11.56
|
4.428 | 23.93 | 11.19 | 10.19 |
| Depreciation and Amortization |
5.39%
0.665
|
0.631 | 0.563 | 0.584 | 0.559 |
| Operating Income/Loss |
158.37%
-11.40
|
-4.413 | -23.43 | -11.05 | -9.842 |
| Net Interest Income/Expense |
13.04%
-0.02
|
-0.023 | -0.026 | -0.029 | -0.025 |
| Nonoperating Income/Loss |
15.45%
0.142
|
0.123 | 0.48 | 0.194 | 0.10 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
162.47%
-11.26
|
-4.29 | -22.95 | -10.85 | -9.742 |
| Net Income/Loss |
162.47%
-11.26
|
-4.29 | -22.95 | -10.85 | -9.742 |
| Basic Average Shares |
6.46%
36.75
|
34.52 | - | 32.03 | 32.02 |
| Diluted Average Shares |
6.46%
36.75
|
34.52 | - | 32.03 | 32.02 |
| Basic Earnings Per Share |
158.33%
-0.31
|
-0.12 | - | -0.34 | -0.30 |
| Diluted Earnings Per Share |
158.33%
-0.31
|
-0.12 | - | -0.34 | -0.30 |
5.83%
4.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):